arrow
Ó

Óscar Palomares

school of chemistry complutense university
H指数:52
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Natural Diversity of Grass Pollen in Europe—An EAACI Perspective

欧洲草花粉的自然多样性—<scp>EAACI</scp>观点

2026-10-080
PREAI
Bioassays in Allergy: Technical Characteristics, Limitations, and Pathways to Clinical Implementation—An EAACI Position Paper

过敏中的生物测定:技术特征、局限性及临床实施途径——EAACI立场文件

2026-10-010
OAAI
Restoring epithelial health in epithelial-driven disease through an early treat-to-target approach: improving patient care towards clinical remission

通过早期靶向治疗策略恢复上皮驱动的疾病中的上皮健康:改善患者护理以实现临床缓解

2026-09-300
OAAI
ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases

ARIA-EAACI 2025:气道疾病中以患者为中心、数字化赋能和人工智能辅助的变革管理

2026-09-030
OAAI
Common Food Emulsifiers Impair Epithelial Barrier Integrity and Trigger Pro-Inflammatory Responses and IgE Production

常见食品乳化剂损害上皮屏障完整性并触发促炎反应和IgE产生

2026-08-100
OAAI
The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Utricaria, and Chronic Rhinosinusitis With Nasal Polyps

首个用于过敏领域的生物类似药:CT-P39(Omlyclo-Omalizumab-Igec)适用于哮喘、慢性自发性荨麻疹和伴有鼻息肉的慢性鼻窦炎

2026-04-250
PRE
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第II部分—口服和眼部治疗指南

2026-03-240
OAAI
Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules

慢性炎症性疾病中非生物和基于RNA的疗法的更新: 通过小分子的精准医学

2026-02-070
OAAI
The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways—An EAACI Position Paper

上气道炎症性疾病中嗅觉测试的未满足需求——EAACI立场文件

2026-02-020
PRE
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments

变应性鼻炎及其对哮喘的影响(ARIA)-EAACI指南—2024–2025年修订版:第一部分—关于鼻内治疗的指南

2025-12-010
OAAI
EAACI Guidelines on the Importance of Green Space in Urban Environments for Allergy and Asthma Prevention

EAACI指南:城市环境中绿色空间对于过敏和哮喘预防的重要性

2025-12-010
PRE
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms

过敏性鼻炎及其对哮喘的影响(ARIA)-EAACI 2024–2025指南的开发方法:从证据到决策框架到数字化共享决策算法

2025-11-210
OAAI
Molecular Signatures and Functional Pathways of Human Monocytes and Macrophages in Allergy: An EAACI AllergoOncology Scoping Review

人类单核细胞和巨噬细胞在过敏中的分子特征与功能通路:EAACI AllergoOncology 范围综述

2025-08-290
OAAI
A mucosal vaccine prevents eosinophilic allergic airway inflammation by modulating immune responses to allergens in a murine model of airway disease

一种黏膜疫苗通过调节对过敏原的免疫反应,预防小鼠气道疾病模型中的嗜酸性粒细胞过敏性气道炎症。

2025-08-030
OAAI
Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation

大麻素WIN55,212-2通过调节氧化应激和STAT6磷酸化来恢复支气管上皮。

2025-05-160
OAAI
Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction: The Role of Allergy and Immunity-An EAACI Position Paper

分泌性中耳炎(OME)与咽鼓管功能障碍:过敏与免疫的作用——EAACI立场文件

2025-04-170
PREAI